Rating History for Ligand Pharma (LGND) by Oppenheimer

More Stocks Rated by Oppenheimer | Latest Ratings for LGND
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
5/4/2026 Leland Gershell New Coverage Outperform
(N/A)		 285.00
(N/A)		 227.44
(262.17)		 15.27% Details